22 Slides Presentation Deck

Endocrinology Platform Overview Deck

Presentation-ready overview of ArcaScience's AI-driven benefit-risk analysis capabilities for endocrinology, designed for endocrinology drug development teams, metabolic safety scientists, and diabetes regulatory affairs.

Download Slide Deck

What's Inside

A 22-slide deck covering the full ArcaScience platform configured for endocrinology, from data coverage through regulatory outputs. Ready for internal presentations, steering committees, and vendor evaluations.

01

Endocrinology BRA landscape

02

GLP-1 RA safety profiling

03

SGLT2 cross-indication BRA

04

Hypoglycemia quantification

05

Obesity BRA framework

06

CVOT analysis

07

Regulatory requirements

08

Case study highlights

Featured Slide Previews

GLP-1 RA Safety Profiling

Comprehensive safety assessment for GLP-1 receptor agonists covering GI tolerability, pancreatitis signals, thyroid C-cell tumor monitoring, and gallb...

Hypoglycemia Quantification

Multi-level hypoglycemia risk assessment (Level 1/2/3) integrating continuous glucose monitoring data, patient-reported events, and nocturnal hypoglyc...

SGLT2 Cross-Indication BRA

Unified benefit-risk assessment across diabetes, heart failure, and CKD indications for SGLT2 inhibitors, with DKA and amputation risk contextualizati...

Get the Full Endocrinology Platform Overview Deck

Complete the form below to receive the document via email.

By downloading, you agree to our Privacy Policy.

More Endocrinology Resources

PDF Whitepaper

Endocrinology BRA Methodology Guide

Case Studies

Endocrinology Case Study Collection

Regulatory Guide

Endocrinology Regulatory Landscape

See ArcaScience for Endocrinology

Request a live demonstration of ArcaScience configured for endocrinology benefit-risk analysis. Our scientists will show TA-specific data, AI models, and regulatory outputs relevant to your program.

Request Endocrinology Demo